skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

About Michael

Washington DC, {6D506EDE-F0E4-4964-93FF-D8A3DA23BDA0}

+3 year(s) experience

Michael is a writer based in Washington DC who covers FDA regulatory policy. He frequently attends and reports on FDA advisory committee meetings, public workshops and congressional hearings. He is a regular contributor to the Pink Sheet's FDA Performance Tracker, and additionally focuses on expanding coverage into the Latin and South America regions.

Michael is a regular at FDA's White Oak campus covering advisory committee meetings and public workshops on a variety of drug development areas. He has also written on a wide range of congressional hearings on topics such as drug pricing, user fee reauthorizations, opioids and the 21st Century Cures Act.

Michael is a weekly contributor to the Pink Sheet's "Keeping Track" column, and has authored several data-driven stories examining drug development trends. In his free time, Michael can be found cheering on  - although often futilely - the New York Mets, Jets and Knicks.

Specialties

  • Policy & Regulation
  • Generics

Michael Writes For

Analyst Articles

Articles by Michael